Elisabeth Leiderman's most recent trade in Bluebird bio Inc was a trade of 49,850 Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 6, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bluebird bio Inc | Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 47,156 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,600 | 21,600 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 10,790 | 22,256 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Sale of securities on an exchange or to another person at price $ 6.46 per share. | 17 Oct 2022 | 1,004 | 11,466 (0%) | 0% | 6.5 | 6,490 | Common Stock |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 3,109 | 12,470 (0%) | 0% | 0 | Common Stock | |
| Decibel Therapeutics Inc | Elisabeth Leiderman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 52,500 | 52,500 | - | - | Stock Options (right to buy) | |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Nov 2021 | 15,057 | 15,057 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 9,361 | 9,361 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Elisabeth Leiderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 4,663 | 4,663 (0%) | 0% | 0 | Common Stock |